Porogen

What Porogen does

PoroGen B.V. is a privately held Dutch life sciences company founded in 2007, headquartered in Bilthoven, the Netherlands. The company has developed proprietary free-form biomaterial fabrication processes that combine CAD/CAM and Rapid Prototyping technologies to produce porous medical devices with designed 3D macroporous architectures — enabling independent control over both exterior device geometry and interior porous structure across polymers, ceramics, metals, and composites. PoroGen operates through two divisions: a Biomaterial Services line providing standardized stock and custom 3D reference scaffolds (ceramic and polymer) for biomedical research, tissue engineering, stem cell research, and drug delivery applications; and a Medical Implants line offering design, development, and contract manufacturing of custom, patient-specific porous implants in a cGMP-compliant facility (planned for end-2008).

The company generates revenue through a B2B direct sales model targeting biomedical research institutions and medical device companies, with revenue streams including one-time license purchases of stock reference scaffolds and professional services engagements for custom scaffold manufacturing and contract medical device production. Pricing is quote-based and not publicly disclosed. Founder and Director Clayton Wilson (advanced degrees in biomaterials and tissue engineering from Rensselaer Polytechnic Institute and the University Medical Center Utrecht) leads the company, supported by Scientific and Business Advisor Professor Clemens van Blitterswijk (former CEO of IsoTis NV, where he raised over €120M and advanced 10 implant technologies into clinical evaluation). Capitalization to date consists of non-dilutive Dutch government grants: a €250,000 BioPartner First-Stage grant (2004) and participation in the €15M SmartMix TeRM consortium coordinated by the University of Twente (2007), targeting clinically applicable scaffolds for cell-based cartilage and other tissue therapies.

Name

Porogen

Legal name

PoroGen B.V.

Website

https://porogen.nl

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1–10 employees

Short description

PoroGen B.V. is a privately held Dutch life sciences startup that uses proprietary CAD/CAM and Rapid Prototyping processes to manufacture 3D reference scaffolds and custom porous medical implants with designed macroporous architectures for biomedical research institutions and medical device companies.

Ownership category

akta.pro rank

Product category

Biomaterial Scaffold and Medical Implant Manufacturing

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

3D Bioprinting & Biofabrication (HLAAAGAC)

akta.pro secondary industries

Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB), Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware) (IMAAAAAG), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI)

Keywords

• Biomaterial scaffolds
• Medical implant manufacturing
• Porous tissue engineering
• Contract medical devices
• 3D macroporous scaffolds

Headquarters

HQ city

Bilthoven

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. 3D Reference Scaffolds: Stock reference scaffolds in ceramic and polymer materials for biomedical research, tissue engineering, drug delivery and related R&D activities. Consistent material and physical properties provide stable platform for biomaterials research.
2. Custom Scaffold Manufacturing: Made-to-order services ranging from simple modifications to stock products to unique designs in customer supplied materials. Includes customer specified design with pilot series followed by production.
3. Medical Device Manufacturing Services: Contract manufacturing of medical devices using unique technologies. Services include design and development of customer specified devices produced in cGMP facility.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

PoroGen develops and manufactures porous biomaterial devices with designed 3D macroporous architectures using proprietary CAD/CAM and Rapid Prototyping fabrication processes. The company sells standardized 3D reference scaffolds in ceramic and polymer materials for biomedical research, and provides custom design, development, and cGMP contract manufacturing services for medical implants and patient-specific devices.

Product overview

PoroGen operates as a dual-pathway company offering Biomaterial Services and Medical Implants. The Biomaterial Services division provides stock and custom 3D reference scaffolds with designed macroporous architectures using CAD/CAM and Rapid Prototyping technologies, available in ceramic (Hydroxyapatite, TCP, BCP) and polymer (PLA, PGA, PEG/PBT) materials. The Medical Implants division offers design, development, and contract manufacturing services for custom medical devices, applying PoroGen's proprietary free-form fabrication technologies that enable production of porous constructs with designed 3D macroporous structures in polymers, ceramics, metals, and composites.

Differentiator

Problem solved

Functional benefit

Products and services

• Reference Scaffolds
• Ceramic Scaffolds
• Polymer Scaffolds
• Made-to-Order Custom Scaffolds
• Design and Development Services
• Medical Implants Manufacturing

Quantifiable outcome

• Approximately 50% porosity in reference scaffolds
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• University of TwenteflagshipStrategic or Co-development PartnerUniversity of Twente coordinates the €15 million TeRM (Translational excellence in Regenerative Medicine) consortium program that includes PoroGen. The collaboration focuses on developing free-form biomaterial manufacturing technology for clinically applicable scaffolds supporting cell based therapies.
• TeRM Consortium PartnerscoreStrategic or Co-development PartnerTeRM consortium partners, alongside PoroGen and University of Twente, working on the Translational excellence in Regenerative Medicine program for developing biomaterial manufacturing technologies.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Materialise: Established Belgian 3D printing company with a sizable medical segment offering patient-specific implants, surgical planning, and CMF solutions — a broader incumbent competing in PoroGen's end markets.
• Stratasys: Large public 3D printing company with healthcare applications including anatomic models and patient-specific surgical guides; a broad incumbent in medical additive manufacturing adjacent to PoroGen's niche.

Direct peers

• NovaBone Products: US manufacturer of bone graft substitutes and porous calcium-phosphate-based scaffolds for orthopedic and dental use, overlapping with PoroGen's ceramic scaffold product line.
• Cellink (BICO): Global 3D bioprinting platform offering bioprinters, bioinks, and application workflows for tissue engineering and regenerative medicine — overlapping with PoroGen's biomaterial scaffold offerings.
• BellaSeno: European (German/Portuguese) 3D-printed scaffold company producing resorbable patient-specific scaffolds for bone and soft tissue regeneration — directly comparable in product type and clinical application to PoroGen.
• Dimension Inx: US-based developer of 3D-printed biomaterial scaffolds and regenerative implants using designed porous architectures, closely matching PoroGen's tissue engineering and implant manufacturing focus.
• Tissue Regeneration Systems: Developer of 3D-printed bioresorbable bone and skeletal tissue scaffolds, directly comparable to PoroGen's patient-specific bone and porous implant manufacturing offering.
• regenHU: Swiss bioprinter manufacturer offering 3D biofabrication systems and biomaterials for regenerative medicine research and implant development — comparable technology stack to PoroGen.
• Organovo: Pioneer in 3D bioprinted human tissues for research and therapeutic applications; historically one of the closest publicly visible peers to PoroGen in 3D biofabrication of tissue constructs.
• Aspect Biosystems: Canada-based 3D bioprinting company focused on tissue therapeutics and designed tissue architectures, competing in the same regenerative medicine and tissue engineering space as PoroGen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Porogen